NEJM (The New England Journal of Medicine)

Ir al canal en Telegram

All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

EEUU1 458 Medicina783...

📈 Análisis del canal de Telegram NEJM (The New England Journal of Medicine)

El canal NEJM (The New England Journal of Medicine) (@the_nejm) en el segmento lingüístico de Inglés es un actor destacado. Actualmente la comunidad reúne a 26 718 suscriptores, ocupando la posición 783 en la categoría Medicina y el puesto 1 458 en la región EEUU.

📊 Métricas de audiencia y dinámica

Desde su creación el невідомо, el proyecto ha mostrado un crecimiento acelerado, reuniendo a 26 718 suscriptores.

Según los últimos datos del 20 julio, 2026, el canal mantiene una actividad estable. En los últimos 30 días la variación de miembros fue de 359, y en las últimas 24 horas de 5, conservando un alto alcance.

Estado de verificación: No verificado
Tasa de interacción (ER): El promedio de interacción de la audiencia es 6.90%. Durante las primeras 24 horas tras publicar, el contenido suele obtener 2.76% de reacciones respecto al total de suscriptores.
Alcance de las publicaciones: Cada publicación recibe en promedio 1 843 visualizaciones. En el primer día suele acumular 736 visualizaciones.
Reacciones e interacción: La audiencia responde de forma activa: el promedio de reacciones por publicación es 2.
Intereses temáticos: El contenido se centra en temas clave como medicine, journal, print, cancer, patient.

📝 Descripción y política de contenido

El autor describe el recurso como un espacio para expresar opiniones subjetivas:
“All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicin...”

Gracias a la alta frecuencia de actualizaciones (últimos datos recibidos el 21 julio, 2026), el canal mantiene la vigencia y un amplio alcance. La analítica demuestra que la audiencia interactúa activamente con el contenido, lo que lo convierte en un punto de referencia dentro de la categoría Medicina.

26 718

Suscriptores

+524 horas

+807 días

+35930 días

1 843

Visitas de la publicación

~ 73624 horas

~ 95448 horas

6.90%

Tasa de compromiso

~ 2

Mensajes por día

Ads index

beta

Archivo de publicaciones

26 718

When Celebrities Prescribe — Regulating Drug Promotion on the Internet https://www.nejm.org/doi/full/10.1056/NEJMp2602486?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Love and Death https://www.nejm.org/doi/full/10.1056/NEJMp2516818?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

National Elimination of Hepatitis C — The Case for Starting in Prisons and Jails https://www.nejm.org/doi/full/10.1056/NEJMp2602773?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Neurocysticercosis https://www.nejm.org/doi/full/10.1056/NEJMicm2603020?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vaccine Protection https://www.nejm.org/doi/full/10.1056/NEJMp2605103?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease https://www.nejm.org/doi/full/10.1056/NEJMoa2517588?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 233-242, July 16, 2026.

26 718

Lead Lines in Severe Lead Poisoning https://www.nejm.org/doi/full/10.1056/NEJMicm2603074?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 290-290, July 16, 2026.

26 718

Time to Stop? Rethinking the Duration of Maintenance Treatment in Multiple Myeloma https://www.nejm.org/doi/full/10.1056/NEJMe2604761?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 302-303, July 16, 2026.

26 718

Targeted Degradation of NETs in Lupus with DNASE1L3 Deficiency https://www.nejm.org/doi/full/10.1056/NEJMc2601997?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 308-310, July 16, 2026.

26 718

Large-Scale Premarital Genetic Screening in the United Arab Emirates https://www.nejm.org/doi/full/10.1056/NEJMc2510402?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 306-308, July 16, 2026.

26 718

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis https://www.nejm.org/doi/full/10.1056/NEJMc2602619?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 311-312, July 16, 2026.

26 718

Andes Virus — A Clinical Review https://www.nejm.org/doi/full/10.1056/NEJMra2606651?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

A Regional Measles Outbreak — South Carolina, 2025–2026 https://www.nejm.org/doi/full/10.1056/NEJMc2605131?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

NEJM This Week — July 16, 2026 http://www.nejm.org/toc/nejm/395/3 This week, we present advances in the treatment of multiple myeloma, systemic lupus erythematosus, and coronary artery disease, alongside new national data on health care–associated infections. We also review fibromyalgia and the emerging Bundibugyo virus outbreak, follow a surprising diagnostic case of alpha-gal syndrome, and explore Perspectives on caring for vulnerable patients, trustworthy health information, pharmacotherapeutic decisions in autism care, and the experience of caring for a parent with dementia.

26 718

NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care. http://www.nejm.org/doi/full/10.1056/NEJMp2602649 Yaara Zisman-Ilani is an associate professor in the Department of Social and Behavioral Sciences at the Barnett College of Public Health and in the Department of Psychiatry and Behavioral Science at the Lewis Katz School of Medicine, both at Temple University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Zisman-Ilani and Others. Pharmacotherapeutic Decisions in Autism. N Engl J Med 2026;395:214-217.

26 718

Platelet-Activating Anti–Platelet Factor 4 Disorders https://www.nejm.org/doi/full/10.1056/NEJMra2502459?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty https://www.nejm.org/doi/full/10.1056/NEJMoa2603649?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Pharmacotherapeutic Decisions in Autism https://www.nejm.org/doi/full/10.1056/NEJMp2602649?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Descending Thoracic Aortic Aneurysm https://www.nejm.org/doi/full/10.1056/NEJMicm2505469?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

The Exam Room as Sanctuary — Caring for Undocumented Patients https://www.nejm.org/doi/full/10.1056/NEJMp2603126?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.